Skip to main content

Telehealth to make follow-up care easier for transplant patients

January 16, 2020
Bryna Rickett, RN, left, explains the telehealth software to Dr. Karim Soliman as he conducts a test run with the Columbia Nephrology site. Photo by Sarah Pack

Transplant patients and living donors in South Carolina are getting more options for follow-up care closer to home.

Once a patient undergoes transplant surgery at MUSC Health, the organ recipient needs to visit the doctor every month for the first year. That’s a lot of visits for someone who doesn’t live in the Charleston area or near an MUSC Health regional hospital. Thus, transplant nephrologist Karim Soliman, M.D., is excited about the expanding telehealth options for kidney and pancreas transplant patients.

MUSC Health is partnering with Columbia Nephrology to allow patients who live in the Midlands to go to their monthly check-ins with their MUSC Health doctors via a telehealth linkup at the practice’s office in Columbia. The telehealth option should make life a lot easier for patients who now drive for hours to get to a Charleston appointment, Soliman said.

Carole Ann Norman, Columbia Nephrology practice manager, said many patients struggle financially to travel regularly to Charleston.

“This will help alleviate some of that stress and burden of having to travel back and forth,” she said. She hopes the psychological relief will help lead to better physical health.

The partnership follows a launch of the transplant telehealth service at Tidelands Health in Murrells Inlet in 2019. The Murrells Inlet location has been successful in providing telehealth services for several months now, said Daniel Stanton, administrator of the MUSC Transplant Center, and with an even greater number of transplant patients living in the Midlands area of South Carolina he expects to see a good number take advantage of the Columbia Nephrology partnership.

The service is also available to living donors, Stanton said. Donors have follow-up visits at one month, six months, one year and two years after surgery. Even though they don’t have as many checkups as the recipients, donors are generally healthy working adults who don’t necessarily have time to drive all the way to Charleston for an appointment.

“Telehealth is really a fantastic option for them,” Stanton said.

Already, the Transplant Center has seen donors improve their follow-up visit rate from about 60% to almost 100%, an improvement that Stanton attributed partly to increased efforts by staff to stress the importance of follow-up visits and partly to the convenience of telehealth.

And MUSC Health has not forgotten those in the Upstate. The health system is establishing a clinic in Greenville, planned for the first quarter of 2020, that will have a full-time nurse practitioner on site; monthly in-person visits from kidney, lung, heart and liver doctors; and a telehealth option for transplant patients as well.

While the kidney program has been in the vanguard of transplant telehealth, “there has been a lot of enthusiasm and excitement from our other transplant programs,” Stanton said.

Once the infrastructure and routines are in place, he can envision other transplant services also offering telehealth follow-up options.

Meet the Author
Leslie Cantu Hollings Cancer Center Staff wearing a blue dress shirt

Leslie Cantu

Senior Communications Manager

Leslie Cantu is the senior communications manager at MUSC Hollings Cancer Center, where she works with researchers, clinicians and patients to tell the people of South Carolina about the innovative work being done to improve cancer care for everyone in the state. She joined the MUSC Office of Communications and Marketing in 2018 after a career as an award-winning writer, editor and producer at community newspapers and local TV news. She transferred to the communications office at Hollings in 2022, where she happily finds something new and interesting to write about every day. Her favorite stories to cover at MUSC have included Match Day, the Angel Tree Parade, a clinical trial of CAR-T cell therapy and the many patients who have agreed to share their very personal struggles and triumphs.

Recent Patient Journeys stories